EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GPR27 expression correlates with prognosis and tumor progression in gliomas

Changcheng Cai, Libo Hu, Ke Wu, Yinggang Liu

PeerJ · 2024

DOI: 10.7717/peerj.17024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Changcheng Cai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Suining Central Hospital, Suining, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds Glioma is a highly aggressive type of brain tumor, and its prognosis is still poor despite recent progress in treatment strategies. G protein-coupled receptor 27 (GPR27) is a member of the G protein-coupled receptor family and has been reported to be involved in various cellular processes, including tumor progression. Nevertheless, the clinical potential and tumor-related role of GPR27 in glioma remain unknown. Here we aimed to explore the function and role of GPR27 in gliomas.

Methods

In the current study, we evaluated the expression and clinical significance of GPR27 in gliomas using data from The Cancer Genome Atlas (TCGA) datasets. We also conducted cellular experiments to evaluate the functional role of GPR27 in glioma cell growth.

Results

We found that GPR27 expression level was closely associated with disease status of glioma. Of note, GPR27 was negatively correlated with WHO grade, with grade IV samples showing the lowest GPR27 levels, while grade II samples showed the highest levels. Patients with IDH mutation or 1p/19q co-deletion exhibited higher GPR27 levels. In addition, lower GPR27 levels were correlated with higher death possibilities. In cellular experiments, we confirmed that GPR27 inhibited glioma cell growth.

Conclusions

Our results indicate that GPR27 may function as a potential prognostic biomarker and therapeutic target in gliomas. Further studies are needed to illustrate the signaling mechanism and clinical implications of GPR27 in gliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaHumansChromosome AberrationsMutationNeoplastic ProcessesReceptors, G-Protein-Coupled

Stichwörter der Autor:innen

BiomarkersCell proliferationGlioblastomaMolecular biologyNeuroscienceSurvival analysis

Substanzen

Receptors, G-Protein-CoupledGPR27 protein, human

Autor:innen und Institutionen

  • Suining Central Hospital, Suining, China.
  • Xichang People's Hospital, Xichang, China.

Zitieren

APA

Cai, C., Hu, L., Wu, K., & Liu, Y. (2024). GPR27 expression correlates with prognosis and tumor progression in gliomas. PeerJ. https://doi.org/10.7717/peerj.17024

Vancouver

Cai C, Hu L, Wu K, Liu Y. GPR27 expression correlates with prognosis and tumor progression in gliomas. PeerJ. 2024. doi:10.7717/peerj.17024

BibTeX
@article{Cai2024,
  author = {Cai, Changcheng and Hu, Libo and Wu, Ke and Liu, Yinggang},
  title = {GPR27 expression correlates with prognosis and tumor progression in gliomas},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.17024}
}
Kostenlos starten →